Comparing Jardiance vs Semaglutide
| Jardiance (empagliflozin) | Semaglutide |
|
|---|
| Jardiance (empagliflozin) | Semaglutide |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Jardiance is an oral medication that may be used to treat type 2 diabetes, improve outcomes in people with chronic kidney disease, or reduce the risk of cardiovascular death in some populations... View more |
Prescription only
Semaglutide (Ozempic, Rybelsus) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
Related suggestions Cardiovascular Risk Reduction
Chronic Kidney Disease
|
|||||||
| More about Jardiance (empagliflozin) | More about Semaglutide | ||||||||
| Ratings & Reviews | |||||||||
|
Jardiance has an average rating of 5.3 out of 10 from a total of 327 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 42% reported a negative effect. |
Semaglutide has an average rating of 6.9 out of 10 from a total of 2690 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Jardiance side effects |
View all Semaglutide side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Jardiance prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
|
N/A |
Ozempic, Rybelsus, Wegovy | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
12.4 hours |
168 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 431 drugs are known to interact with Jardiance:
|
A total of 273 drugs are known to interact with Semaglutide:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
August 01, 2014 |
December 05, 2017 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Farxiga
Farxiga (dapagliflozin) is an oral prescription medication that may be given to certain adults with ...
Lasix
Lasix is a loop diuretic used to treat fluid retention from heart, liver, or kidney conditions, and ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Kerendia
Kerendia is used for the treatment of patients with chronic kidney disease (CKD) associated with ...
Sotagliflozin
Sotagliflozin is used for chronic kidney disease, heart failure, type 2 diabetes
Dapagliflozin
Dapagliflozin (Farxiga) is an SGLT2 inhibitor that is mainly used alongside diet and exercise to ...
Semaglutide
Semaglutide is a GLP-1 agonist used for weight loss, type 2 diabetes, and reducing cardiovascular ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.